Clinical trials
Weight Loss trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 15 |
| 2017 | 5 |
| 2018 | 10 |
| 2019 | 17 |
| 2020 | 19 |
| 2021 | 15 |
| 2022 | 17 |
| 2023 | 21 |
| 2024 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 180 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Miriam Hospital | 5 |
| Hospital General Universitario Elche | 3 |
| Laval University | 3 |
| Mansoura University | 3 |
| Universidad de Sonora | 3 |
| University of Illinois at Urbana-Champaign | 3 |
| American University of Beirut Medical Center | 2 |
| National University Hospital, Singapore | 2 |
| Oregon Health and Science University | 2 |
| ReShape Lifesciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 180 |
| Obesity | 98 |
| Overweight | 28 |
| Obesity, Morbid | 12 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 9 |
| Metabolic Syndrome | 7 |
| Malnutrition | 6 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Insulin Resistance | 5 |
Trials
Showing 1 to 25 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.